Osteoporosis Market to Cross $40 Billion by 2019: Amgen, Eli Lilly Dominate the Worldwide Osteoporosis Drugs Industry

Oct 30, 2015, 04:00 ET from RnR Market Research

PUNE, India, October 30, 2015 /PRNewswire/ --

The "Global Osteoporosis Market, Patients, Companies & Forecast" is a 2015 research report providing a comprehensive analysis of the current state and likely future evolution of osteoporosis over the next 5 years.

Complete report on osteoporosis market spread across 124 pages, talking about 5 major companies and supported with 8 tables and 89 figures is now available at http://www.rnrmarketresearch.com/global-osteoporosis-market-patients-companies-forecast-market-report.html .

Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.

The latest research titled "Global Osteoporosis Market, Patients, Companies & Forecast" provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 viewpoints including Osteoporosis Patients & Forecast, Hip fracture Patients & Forecast, Osteoporosis Market & Forecast, Country Wise Osteoporosis level of Awareness, Guidelines & Policy, Country Wise Reimbursement of Medication as well as Company Wise Osteoporosis Drugs Sales & Forecast .

The 10 Countries studied in the report cover India, China, Japan, Korea, Brazil, Russia, United Kingdom, France, Germany and United States. Worldwide Osteoporosis - Company Wise Drugs Sales Analysis (2010 - 2019) is provided for Merck, Sanofi, Novartis, Eli Lilly and Amgen. Order a copy of this osteoporosis market report at http://www.rnrmarketresearch.com/contacts/purchase?rname=419485 .

Widespread vitamin D deficiency, low calcium intake and globally increasing ageing population & life expectancy are the major growth factors for the osteoporosis market. Challenges like lack of reimbursement / other restrictions for reimbursement, limited access of diagnostic tools & low levels of public and health professional awareness and lack of government osteoporosis policy, guidelines & national health priority in Asia Pacific countries are discussed in the report.

On similar lines, RnRMarketResearch.com offers another research titled Osteoporosis Drugs Market in BRIC Nations 2015-2019 that forecasts a 17.43% CAGR for BRIC nations' osteoporosis drugs market to 2019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of osteoporosis. Pharmaceutical products are classified as branded and generic drugs. The report covers Brazil, Russia, India, and China; it also covers the landscape of the osteoporosis drugs market in BRIC nations and its growth prospects in the coming years. Amgen, Eli Lilly, Merck, Novartis, Abiogen Pharma, Deltanoid Pharmaceuticals, F. Hoffmann La Roche, GlaxoSmithKline, IMMD, Ligand Pharmaceuticals, Pantarhei Bioscience, Pfizer, PhytoHealth, Radius Health, UPSHER-SMITH LABORATORIES and Zosano Pharma are companies mentioned in this research available at http://www.rnrmarketresearch.com/osteoporosis-drugs-market-in-bric-nations-2015-2019-market-report.html .

Explore more reports on osteoporosis drugs at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/osteoporosis-drugs .

About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com


SOURCE RnR Market Research